EUVIMEDEUVIMED entdecken
Crossref

Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice

Xinyi Du, Shaoting Guo, Xuemeng Mu, Song Mei, Rui Yang, Hengyan Zhang, Chengyu Jiang iD, Jia Zhang

IUBMB Life · 2024

DOI: 10.1002/iub.2857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Xinyi Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, Osteoclasts, Bone Density. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Higher Education Discipline Innovation Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis (OP) is a systemic metabolic bone disease resulting in reduced bone strength and increased susceptibility to fractures, making it a significant public health and economic problem worldwide. The clinical use of anti‐osteoporosis agents is limited because of their serious side effects or the high cost of long‐term use. The Xianlinggubao (XLGB) formula is an effective traditional Chinese herbal medicine commonly used in orthopedics to treat osteoporosis; however, its mechanism of action remains unclear. In this study, we screened 40 small RNAs derived from XLGB capsules and found that XLGB28‐sRNA targeting TNFSF11 exerted a significant anti‐osteoporosis effect in vitro and in vivo by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis. Oral administration of bencaosome [16:0 Lyso PA+XLGB28‐sRNA] effectively improved bone mineral density and reduced the damage to the bone microstructure in mice. These results suggest that XLGB28‐sRNA may be a novel oligonucleotide drug that promotes osteogenesis and inhibits osteoclastogenesis in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisOsteoporosisOsteoclastsBone DensityDrugs, Chinese HerbalAnimalsMiceFemaleMice, Inbred C57BLCell DifferentiationLiposomesRAW 264.7 CellsDisease Models, AnimalRANK Ligand

Stichwörter der Autor:innen

RNA therapyTNFSF11Xianlinggubaobone deliveryoligonucleotide drugosteoporosissmall RNAtraditional Chinese medicine

Substanzen

Drugs, Chinese HerbalTnfsf11 protein, mouseLiposomesRANK Ligand

Autor:innen und Institutionen

  • State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical Co…
  • Department of Orthopaedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.

ORCID-Profile: Chengyu Jiang

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Higher Education Discipline Innovation Project
  • National Natural Science Foundation of China
  • State Key Laboratory Special Fund
  • Fundamental Research Funds for Central Universities

Zitieren

APA

Du, X., Guo, S., Mu, X., Mei, S., Yang, R., Zhang, H., Jiang, C., & Zhang, J. (2024). Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice. IUBMB Life. https://doi.org/10.1002/iub.2857

Vancouver

Du X, Guo S, Mu X, Mei S, Yang R, Zhang H, et al. Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice. IUBMB Life. 2024. doi:10.1002/iub.2857

BibTeX
@article{Du2024,
  author = {Du, Xinyi and Guo, Shaoting and Mu, Xuemeng and Mei, Song and Yang, Rui and Zhang, Hengyan and Jiang, Chengyu and Zhang, Jia},
  title = {Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2857}
}
Kostenlos starten →